Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Daverio, M. et al. Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units across Europe. JAMA Netw. Open 5, e2246901 (2022).
2. Atis, S. K., Duyu, M., Karakaya, Z. & Yilmaz, A. Citrate Anticoagulation and Systemic Heparin Anticoagulation During Continuous Renal Replacement Therapy among Critically-Ill Children. Pediatr. Res. (2024).
3. Vakil, N. H., Kanaan, A. O. & Donovan, J. L. Heparin-Induced Thrombocytopenia in the Pediatric Population: A Review of Current Literature. J. Pediatr. Pharm. Ther. 17, 12–30 (2012).
4. Sochet, A. A., Wilson, E. A., Das, J. R., Berger, J. T. & Ray, P. E. Plasma and Urinary Fgf-2 and Vegf-a Levels Identify Children at Risk for Severe Bleeding after Pediatric Cardiopulmonary Bypass: A Pilot Study. Med. Res. Arch. 8, 2134 (2020).
5. Kedarnath, M., Alexander, E. C. & Deep, A. Safety and Efficacy of Continuous Renal Replacement Therapy for Children Less Than 10 Kg Using Standard Adult Machines. Eur. J. Pediatr. 182, 3619–3629 (2023).